RTKN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.690800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.050600E-01
Normal-vs-Stage2
7.122600E-01
Normal-vs-Stage3
8.673400E-01
Normal-vs-Stage4
7.863600E-01
Stage1-vs-Stage2
3.417200E-01
Stage1-vs-Stage3
5.013200E-01
Stage1-vs-Stage4
9.502200E-01
Stage2-vs-Stage3
8.308800E-01
Stage2-vs-Stage4
4.641800E-01
Stage3-vs-Stage4
6.077200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.537200E-01
Normal-vs-AfricanAmerican
9.518800E-01
Normal-vs-Asian
7.696000E-01
Caucasian-vs-AfricanAmerican
6.052800E-01
Caucasian-vs-Asian
9.734200E-01
AfricanAmerican-vs-Asian
6.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.639200E-01
Normal-vs-Female
7.725200E-01
Male-vs-Female
9.848000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.652000E-01
Normal-vs-Age(41-60Yrs)
6.489200E-01
Normal-vs-Age(61-80Yrs)
8.440600E-01
Normal-vs-Age(81-100Yrs)
6.156800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.706600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.072400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.159400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.161000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.729600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.508400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.955400E-01
Normal-vs-Daily Drinker
6.439800E-01
Normal-vs-Weekly Drinker
9.117400E-01
Normal-vs-Occasional Drinker
6.073800E-01
Normal-vs-Social Drinker
8.707400E-01
Non Drinker-vs-Daily Drinker
6.578600E-01
Non Drinker-vs-Weekly Drinker
1.337620E-01
Non Drinker-vs-Occasional Drinker
7.904000E-01
Non Drinker-vs-Social Drinker
9.950400E-02
Daily Drinker-vs-Weekly Drinker
2.760000E-01
Daily Drinker-vs-Occasional Drinker
5.617400E-01
Daily Drinker-vs-Social Drinker
2.244000E-01
Weekly Drinker-vs-Occasional Drinker
1.982170E-01
Weekly Drinker-vs-Social Drinker
9.488200E-01
Occasional Drinker-vs-Social Drinker
1.750780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.341200E-01
Normal-vs-Grade 2
2.595000E-01
Normal-vs-Grade 3
2.820000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.356200E-02
Grade 1-vs-Grade 3
5.060300E-02
Grade 1-vs-Grade 4
4.341200E-01
Grade 2-vs-Grade 3
7.808800E-01
Grade 2-vs-Grade 4
2.595000E-01
Grade 3-vs-Grade 4
2.820000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.614800E-01
Normal-vs-NonDiabetic
7.232200E-01
Diabetic-vs-NonDiabetic
3.470200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.157800E-01
Normal-vs-NoPancreatitis
7.425000E-01
Pancreatitis-vs-NoPancreatitis
7.984600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.889200E-01
Normal-vs-N1
6.907000E-01
N0-vs-N1
3.808000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.437800E-01
Normal-vs-TP53-NonMutant
7.408600E-01
TP53-Mutant-vs-TP53-NonMutant
1.582750E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
